CONMED (CNMD) PT Lowered to $40 at JPMorgan

April 30, 2026 9:21 AM

JPMorgan analyst Robbie Marcus lowered the price target on CONMED (NYSE: CNMD) to $40.00 (from $43.00) while maintaining a Neutral rating.

No results found